Murat DEMİR, Canan DEMİR

Oxidative Stress Has a Negative Effect on the Development and Progression of Bladder Cancer

OBJECTIVE In this study, we aimed to investigate the oxidant-antioxidant capacity in bladder cancer according to invasion and degree. METHODS Forty-six patients with bladder cancer and 50 healthy volunteers were included in the study. After 12 h of fasting, 4cc of blood venous blood was taken from these patients. Then, after centrifugation at 5000 rpms for 10 min, the serum portion of the study was completed. The activities of arylesterase (ARE), paraoxanase-1 (PON-1), glutathione reductase (GR), glutathione-S transferase, and protein carbonyl (PC) in serum were measured spectrophotometrically. RESULTS Antioxidant parameters in the serum of patients with bladder tumors were found lower than control group (p=0.001). In addition, PC was found to be higher in the bladder cancer group than in the control group (p=0.001); on the other hand, ARE, PON-1, and GR levels were found to be lower in both high- grade tumors and invasive tumors (p≤0.05). CONCLUSION Oxidative stress is effective in the development and progression of bladder tumors.

PDF

___

1. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424.
2. Jahrreiss V, Pradere B, Laukhtina E, Mori K, Shariat SF. Catalog of exogenous risk factors for bladder carcino- genesis. Curr Opin Urol 2020;30(3):449–56.
3. Sharma C, Yang W, Steen H, Freeman MR, Hemler ME. Antioxidant functions of DHHC3 suppress anti-cancer drug activities. Cell Mol Life Sci 2021;78(5):2341–53.
4. Gunes M, Eryilmaz R, Aslan R, Taken K, Demir H,Demir C. Oxidant-antioxidant levels in patients with bladder tumours. Aging Male 2020;23(5):1176–81.
5. Kundaktepe BP, Sozer V, Durmus S, Kocael PC, Kun- daktepe FO, Papila C, et al. The evaluation of oxidative stress parameters in breast and colon cancer. Medicine (Baltimore) 2021;100(11):e25104.
6. Afsar CU, Gunaldı M, Okuturlar Y, Gedikbası A, Tiken EE, Kahraman S, et al. Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. Int J Clin Exp 2015;8(11):777–80.
7. Lorestani S, Hashemy SI, Mojarad M, Keyvanloo SM, Bahari A, Asadi, M, et al. Increased glutathione reduc- tase expression and activity in colorectal cancer tissue samples: An investigational study in Mashhad, Iran. Middle East J Cancer 2018;9(2):99–104.
8. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Meth- ods Enzymol 1994;233:357–63.
9. Juretic D, Tadijanovic M, Rekic B, Simoen RV, Reiner E, Baricic M. Serum paraoxonase activities in hemodi- alyzed uremic patients: cohort study. Croat Med J 2001;42(2):146–50
10. Habig WH, Pabst MJ, Jakoby WB. Glutathione S- transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249(22):7130–9.
11. Beutler E. Red cell metabolism. A manual of biochem- ical methods. Orlando, FL: Gune and Stratton; 1984.
12. Jakubczyk K, Dec K, Kaldunska J, Kawczuga D, Kochman J, Janda K. Reactive oxygen species - sources, functions, oxidative damage. Pol Merkur Lekarski 2020;48(284):124–7.
13. Lepara Z, Lepara O, Fajkić A, Rebic D, Alic J, Spahovic H. Serum malondialdehyde (MDA) level as a poten- tial biomarker of cancer progression for patients with bladder cancer. Rom J Intern Med 2020;58(3):146–2.
14. Wang Z, Li S, Cao Y, Tian X, Zeng R, Liao DF, et al. Oxidative stress and carbonyl lesions in ulcerative col- itis and associated colorectal cancer. Oxid Med Cell Longev 2016;2016:9875298.
15. Costa NA, Gut AL, Azevedo PS, Fernandes AAH, Polegato BF, Cunha NB, et al. Protein carbonyl, but not malondialdehyde, is associated with ICU mortal- ity in patients with septic shock. J Intensive Care Med 2019;34(8):669–73.
16. DalleDonne I, Milzani A, Colombo R. H2O2-treated actin: assembly and polymer interactions with cross- linking proteins. Biophys J 1995;69(6):2710–9.
17. Musolino C, Alonci A, Allegra A, Saija A, Penna G, Cannavo A, et al. Increase in serum protein car- bonyl groups is associated with more advanced stage of disease in multiple myeloma patients. Biomarkers 2011;16(8):718–9.
18. Panis C, Victorino VJ, Herrera, Freitas LF, De Rossi T, Campos Fc, et al. Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Res Treat 2012;133(3):881–8.
19. Avezov K, Reznick, AZ, Aizenbud D. Time and dose effects of cigarette smoke and acrolein on protein car- bonyl formation in HaCaT keratinocytes. Adv Exp Med Biol 2015;849:57–64.
20. Whongsiri P, Phoyen S, Boonla C. Oxidative stress in urothelial carcinogenesis: measurements of protein carbonylation and ıntracellular production of reactive oxygen species. Methods Mol Biol 2018;1655:109–17.
21. Wieczorek E, Jablonowski Z, Tomasik B, Gromadzin- ska J, Jablonska E, Konecki T, et al. Different gene ex- pression and activity pattern of antioxidant enzymes in bladder cancer. Anticancer Res 2017;37(2):841–8. 22. Cervellati C, Bonaccorsi G, Trentini A, Valachi G,
Sanz J, Squerzanti M, et al. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women. Scand J Clin Lab In- vest 2018;78(1–2):18–24.
23. Romani A, Trentini A, Flier W, Bellini T, Zuliani G, Cervelatti C, et al. Arylesterase activity of paraox- onase-1 in serum and cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia. An- tioxidants 2020;9(5):456.
24. Khodayar MJ, Seghatoleslami M, Salehcheh M. Paraoxonase and arylesterase activities in patients with cancer. Iran J Blo and Cancer 2017;9(1):5–11.
25. Arenas M, Rodríguez E, Sahebkar A. Paraoxonase-1 activity in patients with cancer: A systematic review and meta–analysis. Crit Rev Oncol Hematol 2018; 127:6–14.
26. Michalak S, Szubert S, Moszynski R, Sajdak S, Szpurek D. Serum arylesterase and paraoxonase activities in patients with ovarian tumors. Taiwan J Obstet Gynecol 2014;53(4):490–3
27. Kennedy L, Sandhu JK, Harper ME, Cuperlovic M. Role of glutathione in cancer: from mechanisms to therapies. Biomolecules 2020;10(10):1429.
28. Bansal A, Simon MC. Glutathione metabolism in can- cer progression and treatment resistance. J Cell Biol 2018;217(7):2291–8.
29. Kalinina EV, Gavriliuk LA. Glutathione synthesis in cancer cells. Biochemistry 2020;85(8):895–7.
30. Nunes SC, Serpa J. Glutathione in ovarian cancer: a double-edged sword. Int J Mol Sci 2018;19(7):1882.
31. Desideri E, Ciccarone F, Ciriolo MR. Targeting glu- tathione metabolism: partner in crime in anticancer therapy. Nutrients 2019;11(8):1926.
32. Gecit I, Eryılmaz R, Kavak S, Gecit I, Meral I, Demir H, et al. The prolidase activity, oxidative stress, and ni- tric oxide levels of bladder tissues with or without tu- mor in patients with bladder cancer. J Membrane Biol 2017;250(5):455–9.